These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1642599)

  • 21. Targeting E3 component of alpha-keto acid dehydrogenase complexes.
    Johnson MT; Yang HS; Patel MS
    Methods Enzymol; 2000; 324():465-76. PubMed ID: 10989453
    [No Abstract]   [Full Text] [Related]  

  • 22. Status spongiosus of white matter in newborn Gelbvieh-cross calves.
    O'Toole D; Montgomery DL; Steadman L; O'Rourke B; Russell W; Dennis J
    J Vet Diagn Invest; 2005 Nov; 17(6):546-53. PubMed ID: 16475512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic defects in E3 component of alpha-keto acid dehydrogenase complexes.
    Patel MS; Hong YS; Kerr DS
    Methods Enzymol; 2000; 324():453-64. PubMed ID: 10989452
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Maple syrup urine disease].
    Indo Y; Matsuda I
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maple syrup urine disease].
    Indo Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():783-7. PubMed ID: 12013999
    [No Abstract]   [Full Text] [Related]  

  • 28. Genotyping cattle for inherited congenital myoclonus and maple syrup urine disease.
    Healy PJ; Dennis JA; Windsor PA; Pierce KD; Schofield PA
    Aust Vet J; 2002 Nov; 80(11):695-7. PubMed ID: 12465829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
    Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maple syrup urine disease: the E1beta gene of human branched-chain alpha-ketoacid dehydrogenase complex has 11 rather than 10 exons, and the 3' UTR in one of the two E1beta mRNAs arises from intronic sequences.
    Chuang JL; Cox RP; Chuang DT
    Am J Hum Genet; 1996 Jun; 58(6):1373-7. PubMed ID: 8651316
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.
    Zhang B; Edenberg HJ; Crabb DW; Harris RA
    J Clin Invest; 1989 Apr; 83(4):1425-9. PubMed ID: 2703538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic characterization of maple syrup urine disease in European families.
    Peinemann F; Wendel U; Danner DJ
    Biochem Med Metab Biol; 1993 Dec; 50(3):338-45. PubMed ID: 8123297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
    Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
    Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular defects in the E1 alpha subunit of the branched-chain alpha-ketoacid dehydrogenase complex that cause maple syrup urine disease.
    Zhang B; Zhao Y; Harris RA; Crabb DW
    Mol Biol Med; 1991 Feb; 8(1):39-47. PubMed ID: 1943689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural findings in maple syrup urine disease in Poll Hereford calves.
    Harper PA; Healy PJ; Dennis JA
    Acta Neuropathol; 1986; 71(3-4):316-20. PubMed ID: 3799144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable correction of maple syrup urine disease in cells from a Mennonite patient by retroviral-mediated gene transfer.
    Koyata H; Cox RP; Chuang DT
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):635-9. PubMed ID: 8240269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease.
    Wendel U; Langenbeck U; Seakins JW
    Pediatr Res; 1989 Jan; 25(1):11-4. PubMed ID: 2919111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

  • 40. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
    Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
    Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.